Principal Scientist
Certara UK - Simcyp Division
Oliver Hatley is a Principal Scientist who has been working at Certara UK Limited’s Simcyp Division since 2013. He received his MSc in Drug Discovery Skills at the Kings College London in 2009. He went on to study Intestinal Metabolism with the University of Manchester (CAPKR) and AstraZeneca, focusing on in vitro to in vivo scaling factors, receiving his PhD in 2014. Oliver is part of the translational sciences in DMPK group within the Simcyp Division, and has lead development of the esterase organ and blood in vitro-in vivo scaling strategies. He currently works on the development of special adult populations within the Simcyp Population-based Simulator.
Disclosure information not submitted.
Friday, March 18, 2022
1:15 PM – 2:15 PM ET